| Hemodialysis patients with coronavirus disease 2019: reduced antibody response | Clinical and Experimental Nephrology |
- Medicine: Internal medicine: Specialties of internal medicine: Diseases of the genitourinary system. Urology
- Medicine: Medicine (General)
| 7 | 2021 |
| Effectiveness of SARS‐CoV‐2 vaccines on hemodialysis patients in Japan: A nationwide cohort study | Therapeutic Apheresis and Dialysis |
- Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs
- Medicine: Internal medicine: Specialties of internal medicine: Diseases of the genitourinary system. Urology
- Medicine: Medicine (General)
| 11 | 2022 |
| Efficacy and safety of three new oral antiviral treatment (molnupiravir, fluvoxamine and Paxlovid) for COVID-19：a meta-analysis | Annals of Medicine |
- Medicine
- Medicine: Medicine (General)
- Medicine: Internal medicine
- Medicine: Medicine (General)
- Medicine: Medicine (General)
| 270 | 2022 |
| Effect of Sotrovimab on Hospitalization or Death Among High-risk Patients With Mild to Moderate COVID-19 | JAMA |
- Medicine: Medicine (General)
- Medicine: Internal medicine
- Medicine: Medicine (General)
- Medicine: Medicine (General)
| 176 | 2022 |
| Survival and predictive factors in dialysis patients with COVID-19 in Japan: a nationwide cohort study | Renal Replacement Therapy |
- Medicine: Internal medicine: Specialties of internal medicine: Diseases of the genitourinary system. Urology
- Medicine: Internal medicine: Specialties of internal medicine: Diseases of the genitourinary system. Urology
| 31 | 2021 |
